Related references
Note: Only part of the references are listed.Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy
Nalinda B. Wasala et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Cardiac phenotype determines survival in Duchenne muscular dystrophy
David J. Birnkrant et al.
PEDIATRIC PULMONOLOGY (2016)
BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle
Tahnee L. Kennedy et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2016)
Duchenne muscular dystrophy: CRISPR/Cas9 treatment
Jerry R. Mendell et al.
CELL RESEARCH (2016)
The L-type Ca2+ channel facilitates abnormal metabolic activity in the cTnI-G203S mouse model of hypertrophic cardiomyopathy
Helena Viola et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy
Sandra Murphy et al.
JOURNAL OF PROTEOMICS (2016)
Dystrophin-Deficient Cardiomyopathy
Forum Kamdar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Antisense oligonucleotides in therapy for neurodegenerative disorders
Melvin M. Evers et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Exon skipping therapy for Duchenne muscular dystrophy
Ryszard Kole et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Can't live with or without it: calcium and its role in Duchenne muscular dystrophy-induced muscle weakness. Focus on SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models
Arthur J. Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage
Charlotte Lorin et al.
CARDIOVASCULAR RESEARCH (2015)
Contemporary Cardiac Issues in Duchenne Muscular Dystrophy
Elizabeth M. McNally et al.
CIRCULATION (2015)
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy
Giulio Cossu et al.
EMBO MOLECULAR MEDICINE (2015)
Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
Tirsa L. E. van Westering et al.
MOLECULES (2015)
Dystrophin-glycoprotein complex regulates muscle nitric oxide production through mechanoregulation of AMPK signaling
Joanne F. Garbincius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The emperor's new dystrophin: finding sense in the noise
S. D. Wilton et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice
Corinne A. Betts et al.
SCIENTIFIC REPORTS (2015)
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
Hongmei Lisa Li et al.
STEM CELL REPORTS (2015)
Nanoparticle-Mediated Dual Delivery of an Antioxidant and a Peptide against the L-Type Ca2+ Channel Enables Simultaneous Reduction of Cardiac Ischemia-Reperfusion Injury
Naviin Hardy et al.
ACS NANO (2015)
Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment
Christopher Ballmann et al.
EXPERIMENTAL PHYSIOLOGY (2015)
The Dystrophin Complex: Structure, Function, and Implications for Therapy
Quan Q. Gao et al.
COMPREHENSIVE PHYSIOLOGY (2015)
Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart
Xaver Koenig et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Age-dependent changes in diastolic Ca2+ and Na+ concentrations in dystrophic cardiomyopathy: Role of Ca2+ entry and IP3
Alfredo Mijares et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy
Ying Li et al.
CARDIOVASCULAR RESEARCH (2014)
Hyperactive Adverse Mechanical Stress Responses in Dystrophic Heart Are Coupled to Transient Receptor Potential Canonical 6 and Blocked by cGMP-Protein Kinase G Modulation
Kinya Seo et al.
CIRCULATION RESEARCH (2014)
How Does Calcium Regulate Mitochondrial Energetics in the Heart? - New Insights
Helena M. Viola et al.
HEART LUNG AND CIRCULATION (2014)
Partial restoration of cardiac function with ΔPDZ nNOS in aged mdx model of Duchenne cardiomyopathy
Yi Lai et al.
HUMAN MOLECULAR GENETICS (2014)
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
Thomas Voit et al.
LANCET NEUROLOGY (2014)
ATALUREN TREATMENT OF PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY
Katharine Bushby et al.
MUSCLE & NERVE (2014)
Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial
Kevin M. Flanigan et al.
NEUROMUSCULAR DISORDERS (2014)
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes
Marika Pane et al.
PLOS ONE (2014)
Impaired functional communication between the L-type calcium channel and mitochondria contributes to metabolic inhibition in the mdx heart
Helena M. Viola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Species-specific Inflammatory Responses as a Primary Component for the Development of Glomerular Lesions in Mice and Monkeys Following Chronic Administration of a Second-generation Antisense Oligonucleotide
Kendall S. Frazier et al.
TOXICOLOGIC PATHOLOGY (2014)
Decreased Myocardial Injury and Improved Contractility After Administration of a Peptide Derived Against the Alpha-Interacting Domain of the L-Type Calcium Channel
Helena M. Viola et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy - a case report
Alok Sharma et al.
AMERICAN JOURNAL OF CASE REPORTS (2014)
L-type Ca2+ channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte
Helena M. Viola et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters
Jayalakshmi Ramachandran et al.
BIOCHEMICAL JOURNAL (2013)
Posttranslational modifications of cardiac ryanodine receptors: Ca2+ signaling and EC-coupling
Ernst Niggli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Role of the cytoskeleton in communication between L-type Ca2+channels and mitochondria
Helena M. Viola et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Gene Correction of a Duchenne Muscular Dystrophy Mutation by Meganuclease-Enhanced Exon Knock-In
Linda Popplewell et al.
HUMAN GENE THERAPY (2013)
Wasting mechanisms in muscular dystrophy
Jonghyun Shin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Cardiac phenotype of Duchenne Muscular Dystrophy: Insights from cellular studies
Natalia Shirokova et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Calcium flux balance in the heart
David Eisner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy
Brent J. Barber et al.
JOURNAL OF PEDIATRICS (2013)
Splicing therapy for neuromuscular disease
Andrew G. L. Douglas et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2013)
Gene and cell-mediated therapies for muscular dystrophy
Patryk Konieczny et al.
MUSCLE & NERVE (2013)
The cooperative international neuromuscular research group duchenne natural history studya longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used
Craig M. McDonald et al.
MUSCLE & NERVE (2013)
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Foteini Mourkioti et al.
NATURE CELL BIOLOGY (2013)
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
Rebecca J. Fairclough et al.
NATURE REVIEWS GENETICS (2013)
Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Richard S. Finkel et al.
PLOS ONE (2013)
α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding
Yi Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Functional muscle ischemia in Duchenne and Becker muscular dystrophy
Gail D. Thomas
FRONTIERS IN PHYSIOLOGY (2013)
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
Kan N. Hor et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2013)
Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
Laurence Viollet et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Urocortins Improve Dystrophic Skeletal Muscle Structure and Function through Both PKA- and Epac-Dependent Pathways
Julie Reutenauer-Patte et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Role of RyR2 Phosphorylation at S2814 During Heart Failure Progression
Jonathan L. Respress et al.
CIRCULATION RESEARCH (2012)
Interference with Myostatin/ActRIIB Signaling as a Therapeutic Strategy for Duchenne Muscular Dystrophy
Helge Amthor et al.
CURRENT GENE THERAPY (2012)
Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?
Toshifumi Yokota et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Emerging drugs for Duchenne muscular dystrophy
Vinod Malik et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy
Ali Yilmaz et al.
HEART (2012)
Genetic Therapeutic Approaches for Duchenne Muscular Dystrophy
Helen Foster et al.
HUMAN GENE THERAPY (2012)
Long-Term Preservation of Cardiac Structure and Function After Adeno-Associated Virus Serotype 9-Mediated Microdystrophin Gene Transfer in mdx Mice
Stefanie Schinkel et al.
HUMAN GENE THERAPY (2012)
Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain
Wojciech Mazur et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2012)
AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy
Brian Bostick et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Cell-penetrating Peptides as Versatile Vehicles for Oligonucleotide Delivery
Helerin Margus et al.
MOLECULAR THERAPY (2012)
Gene therapy for muscular dystrophy: Lessons learned and path forward
Jerry R. Mendell et al.
NEUROSCIENCE LETTERS (2012)
Tadalafil Alleviates Muscle Ischemia in Patients with Becker Muscular Dystrophy
Elizabeth A. Martin et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy
Noah Weisleder et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil
Alexis Ascah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Progress in therapy for Duchenne muscular dystrophy
Rebecca J. Fairclough et al.
EXPERIMENTAL PHYSIOLOGY (2011)
Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction
J-H Shin et al.
GENE THERAPY (2011)
Duchenne muscular dystrophy - What causes the increased membrane permeability in skeletal muscle?
David G. Allen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle
Sanjeewa A. Goonasekera et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Endonucleases: tools to correct the dystrophin gene
Joel Rousseau et al.
JOURNAL OF GENE MEDICINE (2011)
Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy
Dawn A. Delfin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
Brian Bostick et al.
MOLECULAR THERAPY (2011)
Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
Alberto Malerba et al.
MOLECULAR THERAPY (2011)
CARDIOMYOPATHY OF DUCHENNE MUSCULAR DYSTROPHY: CURRENT UNDERSTANDING AND FUTURE DIRECTIONS
Christopher F. Spurney
MUSCLE & NERVE (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart
Xaver Koenig et al.
PLOS ONE (2011)
Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
Catherine Moorwood et al.
PLOS ONE (2011)
Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice
Alison R. Amenta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gentamicin-Induced Readthrough of Stop Codons in Duchenne Muscular Dystrophy
Vinod Malik et al.
ANNALS OF NEUROLOGY (2010)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Cross-talk between L-type Ca2+ channels and mitochondria
Helena M. Viola et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
B. Wu et al.
GENE THERAPY (2010)
Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics
Abdallah Fayssoil et al.
HEART FAILURE REVIEWS (2010)
Overexpression of SERCA1a in the mdx Diaphragm Reduces Susceptibility to Contraction-Induced Damage
Kevin J. Morine et al.
HUMAN GENE THERAPY (2010)
Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
Richard S. Finkel
JOURNAL OF CHILD NEUROLOGY (2010)
Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice
Jian Shan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs
DeWayne Townsend et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Alterations in mitochondrial function as a harbinger of cardiomyopathy: Lessons from the dystrophic heart
Yan Burelle et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
TIMELINE OF CARDIAC DYSTROPHY IN 3-18-MONTH-OLD MDX MICE
Christel Van Erp et al.
MUSCLE & NERVE (2010)
Hereditary muscular dystrophies and the heart
M. C. E. Hermans et al.
NEUROMUSCULAR DISORDERS (2010)
Brief Report: Dystrophin Immunity in Duchenne's Muscular Dystrophy.
Jerry R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy
Jeremy Fauconnier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanisms of Muscle Degeneration, Regeneration, and Repair in the Muscular Dystrophies
Gregory Q. Wallace et al.
ANNUAL REVIEW OF PHYSIOLOGY (2009)
RhoA leads to up-regulation and relocalization of utrophin in muscle fibers
Cecile Gauthier-Rouviere et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes
M. Fanchaouy et al.
CELL CALCIUM (2009)
Pharmacological activation of PPARβ/δ stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice
Pedro Miura et al.
HUMAN MOLECULAR GENETICS (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy
Hitoko Ogata et al.
JOURNAL OF CARDIOLOGY (2009)
Cell Based Therapy for Duchenne Muscular Dystrophy
Andrea Farini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
Yi Lai et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes
Helena M. Viola et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism
Douglas P. Millay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice
Kevin J. Sonnemann et al.
PLOS MEDICINE (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice
Brian Bostick et al.
HUMAN GENE THERAPY (2008)
N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice
Nicholas P. Whitehead et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles
Stephanie Lorain et al.
MOLECULAR THERAPY (2008)
Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy
Douglas P. Millay et al.
NATURE MEDICINE (2008)
Stretch-activated channels in the heart: Contributions to length-dependence and to cardiomyopathy
Marie-Louise Ward et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2008)
Calcium antagonists for Duchenne muscular dystrophy
Margaret F. Phillips et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice
Rachid Benchaouir et al.
CELL STEM CELL (2007)
Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy
Maya Khairallah et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript
Steve D. Wilton et al.
MOLECULAR THERAPY (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Transient exposure to hydrogen peroxide causes an increase in mitochondria-derived superoxide as a result of sustained alteration in L-type Ca2+ channel function in the absence of apoptosis in ventricular myocytes
Helena M. Viola et al.
CIRCULATION RESEARCH (2007)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
Samit Hirawat et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Intracellular calcium handling in ventricular myocytes from mdx mice
Iwan A. Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure
DeWayne Townsend et al.
MOLECULAR THERAPY (2007)
First test of a high-density injection protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up
Daniel Skuk et al.
NEUROMUSCULAR DISORDERS (2007)
Autologous transplantation of muscle-derived CD133(+) stem cells in Duchenne muscle patients
Y. Torrente et al.
CELL TRANSPLANTATION (2007)
Pathophysiology of duchenne muscular dystrophy: Current hypotheses
Nicolas Deconinck et al.
PEDIATRIC NEUROLOGY (2007)
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
Maurilio Sampaolesi et al.
NATURE (2006)
Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy
Tatiana Tsoutsman et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Molecular mechanisms of muscular dystrophies: old and new players
Kay E. Davies et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle
Peter J. Woolf et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade
WD Biggar et al.
NEUROMUSCULAR DISORDERS (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Mitochondrial dysfunction and apoptosis underlie the pathogenic process in α-β-crystallin desmin-related cardiomyopathy
A Maloyan et al.
CIRCULATION (2005)
Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy
JL Jefferies et al.
CIRCULATION (2005)
Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers
A Amantana et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Dystrophic heart failure blocked by membrane sealant poloxamer
S Yasuda et al.
NATURE (2005)
Sodium channels as macromolecular complexes: Implications for inherited arrhythmia syndromes
LS Meadows et al.
CARDIOVASCULAR RESEARCH (2005)
CpG-Independent synergistic induction of β-chemokines and a dendritic cell phenotype by orthophosphorothioate oligodeoxynucleotides and granulocyte-macrophage colony-stimulating factor in elutriated human primary monocytes
JH Wang et al.
JOURNAL OF IMMUNOLOGY (2005)
Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse
EW Yeung et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
QL Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor
XHT Wehrens et al.
CIRCULATION RESEARCH (2004)
Heregulin ameliorates the dystrophic phenotype in mdx mice
TOB Krag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CG sequence- and phosphorothioate backbone modification-dependent activation of the NF-κB-responsive gene expression by CpG-oligodeoxynucleotides in human RPMI 8226 B cells
KW Lee et al.
MOLECULAR IMMUNOLOGY (2004)
Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs
C Dell'Agnola et al.
BLOOD (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI
H Amthor et al.
NEUROMUSCULAR DISORDERS (2004)
Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts
MS Rohman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart
YP Yue et al.
CIRCULATION (2003)
Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle
BL Gebski et al.
HUMAN MOLECULAR GENETICS (2003)
Mitochondria in cell death: novel targets for neuroprotection and cardioprotection
MP Mattson et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Vasomodulation by skeletal muscle-derived nitric oxide requires α-syntrophin-mediated sarcolemmal localization of neuronal nitric oxide synthase
GD Thomas et al.
CIRCULATION RESEARCH (2003)
Dystrophin and mutations: one gene, several proteins, multiple phenotypes
F Muntoni et al.
LANCET NEUROLOGY (2003)
Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation
M Eagle et al.
NEUROMUSCULAR DISORDERS (2002)
Molecular mechanisms of myocardial remodeling. The role of aldosterone
C Delcayre et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Desmin cytoskeleton: A potential regulator of muscle mitochondrial behavior and function
Y Capetanaki
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
CJ Mann et al.
JOURNAL OF GENE MEDICINE (2002)
Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin
JM Scott et al.
NEUROMUSCULAR DISORDERS (2002)
The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton
A Hohaus et al.
FASEB JOURNAL (2002)
Regulation of the cardiac L-type Ca2+ channel by the actin-binding proteins α-actinin and dystrophin
A Sadeghi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Function and genetics of dystrophin and dystrophin-related proteins in muscle
DJ Blake et al.
PHYSIOLOGICAL REVIEWS (2002)
Nitric oxide-dependent modulation of sympathetic neural control of oxygenation in exercising human skeletal muscle
B Chavoshan et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Cytochalasin D reduces Ca2+ currents via cofilin-activated depolymerization of F-actin in guinea-pig cardiomyocytes
U Rueckschloss et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Alteration in calcium handling at the subcellular level in mdx myotubes
V Robert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cationic channels in normal and dystrophic human myotubes
C Vandebrouck et al.
NEUROMUSCULAR DISORDERS (2001)
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy
M Sander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy
A Ferrer et al.
GENE THERAPY (2000)
Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy
JE Anderson et al.
CELL TRANSPLANTATION (2000)
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts
SO Marx et al.
CELL (2000)
Share Paper
